Benzinga's Top Upgrades
February 08, 2016 at 08:55 AM EST
Analysts at Jefferies upgraded Supernus Pharmaceuticals Inc (NASDAQ: SUPN) from Hold to Buy. The target price for Supernus ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|